Company / Operating Margin
ENDRA Life Sciences Inc. Operating Margin History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-146080.5%
FY2019
5-year range
-146080.5% / -1315.6%
FY2017-FY2019
Trend
-11003.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -11003% YoY in FY2019, a notable deviation from the 2-year average annual change of -5502%.
Based on SEC 10-K filings.
-146080.5% in FY2019.
Declined from -1315.6% to -146080.5% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, operating margin decreased 11003.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2019 | -146080.5% | -11003.5% |
| FY2018 | -1315.6% | +0.0% |
| FY2017 | -1315.6% | - |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026